An overview of novel and therapeutic approaches to hepatocellular carcinoma--Japanese experiences.
Tanikawa
Kyuichi
K
International Institute for Liver Research, Kurume, Japan.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000517:prevention & control / Q000628:therapy*; D006505:Hepatitis / Q000150:complications; D006801:Humans; D008099:Liver / Q000503:physiopathology; D008113:Liver Neoplasms / Q000401:mortality / Q000517:prevention & control / Q000628:therapy*; D015996:Survival Rate
D000893:Anti-Inflammatory Agents